CARRIE WILKES-HOFFMEISTER: Open Payments
NPI 1154721868 · FARMVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,245 in 210 payments from 16 companies in 2025. Trend: 2023 $2,105 · 2024 $2,575 · 2025 $4,245
Food & beverage: $3,917Education: $328
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $643 |
| Janssen Biotech, Inc. | 27 | $612 |
| Galderma Laboratories, L.P. | 36 | $359 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $332 |
| GENZYME CORPORATION | 9 | $322 |
| Amgen Inc. | 14 | $313 |
| Regeneron Healthcare Solutions, Inc. | 13 | $291 |
| LEO Pharma Inc. | 13 | $273 |
| UCB, Inc. | 16 | $256 |
| Lilly USA, LLC | 15 | $253 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, OTEZLA, NEMLUVIO, Bimzelx, ILUMYA, RINVOQ.
Industry payments across VA — which companies pay providers there.
